302 related articles for article (PubMed ID: 26976285)
1. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
[TBL] [Abstract][Full Text] [Related]
2. Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition.
Kobyliak N; Falalyeyeva T; Beregova T; Spivak M
Endokrynol Pol; 2017; 68(6):659-667. PubMed ID: 29022648
[TBL] [Abstract][Full Text] [Related]
3. New insights on strain-specific impacts of probiotics on insulin resistance: evidence from animal study.
Kobyliak N; Falalyeyeva T; Tsyryuk O; Eslami M; Kyriienko D; Beregova T; Ostapchenko L
J Diabetes Metab Disord; 2020 Jun; 19(1):289-296. PubMed ID: 32550178
[TBL] [Abstract][Full Text] [Related]
4. Probiotic strains of lactobacilli and bifidobacteria alter pro- and anti-inflammatory cytokines production in rats with monosodium glutamate-induced obesity.
Falalyeyeva TM; Leschenko IV; Beregova TV; Lazarenko LM; Savchuk OM; Sichel LM; Tsyryuk OI; Vovk TB; Spivak MY
Fiziol Zh (1994); 2017; 63(1):17-25. PubMed ID: 29975824
[TBL] [Abstract][Full Text] [Related]
5. Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity.
Savcheniuk O; Kobyliak N; Kondro M; Virchenko O; Falalyeyeva T; Beregova T
BMC Complement Altern Med; 2014 Jul; 14():247. PubMed ID: 25030027
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease.
Kobyliak N; Abenavoli L; Falalyeyeva T; Beregova T
Ann Hepatol; 2018; 17(1):153-161. PubMed ID: 29311399
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention.
Savcheniuk OA; Virchenko OV; Falalyeyeva TM; Beregova TV; Babenko LP; Lazarenko LM; Demchenko OM; Bubnov RV; Spivak MY
EPMA J; 2014 Jan; 5(1):2. PubMed ID: 24410812
[TBL] [Abstract][Full Text] [Related]
8. Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity.
Kobyliak N; Falalyeyeva T; Bodnar P; Beregova T
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):123-130. PubMed ID: 27660157
[TBL] [Abstract][Full Text] [Related]
9. [The effect of probiotic therapy on development of experimental obesity in rats caused by monosodium glutamate].
Savcheniuk OA; Virchenko OV; Falalieieva TM; Beregova TV; Babenko LP; Lazarenko LM; Spivak MIa
Fiziol Zh (1994); 2014; 60(2):63-9. PubMed ID: 25007523
[TBL] [Abstract][Full Text] [Related]
10. Effects of polyphenol compounds melanin on NAFLD/NASH prevention.
Belemets N; Kobyliak N; Virchenko O; Falalyeyeva T; Olena T; Bodnar P; Savchuk O; Galenova T; Caprnda M; Rodrigo L; Skladany L; Delev D; Opatrilova R; Kruzliak P; Beregova T; Ostapchenko L
Biomed Pharmacother; 2017 Apr; 88():267-276. PubMed ID: 28110193
[TBL] [Abstract][Full Text] [Related]
11. [Effects of mono-, poly- and composite probiotics on the ulceration caused by restraint stress].
Virchenko OV; Falalyeyeva TM; Beregova TV; Spivak MY; Lazarenko LM; Demchenko OM
Fiziol Zh (1994); 2015; 61(1):35-41. PubMed ID: 26040033
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of probiotic effects of
Bubnov RV; Babenko LP; Lazarenko LM; Mokrozub VV; Demchenko OA; Nechypurenko OV; Spivak MY
EPMA J; 2017 Dec; 8(4):357-376. PubMed ID: 29209439
[TBL] [Abstract][Full Text] [Related]
13. Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice.
Coelho CFF; França LM; Nascimento JR; Dos Santos AM; Azevedo-Santos APS; Nascimento FRF; Paes AMA
J Dev Orig Health Dis; 2019 Apr; 10(2):188-195. PubMed ID: 29855396
[TBL] [Abstract][Full Text] [Related]
14. Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study.
Azarang A; Farshad O; Ommati MM; Jamshidzadeh A; Heydari R; Abootalebi SN; Gholami A
Biomed Res Int; 2020; 2020():5487659. PubMed ID: 33299871
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic effect of probiotic strains Bifidobacterium animalis VKL and VKB on stress-induced lesions in the gastric mucosa of rats].
Spivak MIa; Lazarenko LM; Falalieieva TM; Virchenko OV; Neporada KS
Fiziol Zh (1994); 2013; 59(2):23-30. PubMed ID: 23821934
[TBL] [Abstract][Full Text] [Related]
16. Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice.
Bubnov R; Babenko L; Lazarenko L; Kryvtsova M; Shcherbakov O; Zholobak N; Golubnitschaja O; Spivak M
EPMA J; 2019 Dec; 10(4):317-335. PubMed ID: 31832109
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Probiotics (MCP
Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
[TBL] [Abstract][Full Text] [Related]
18. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J
J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643
[TBL] [Abstract][Full Text] [Related]
19. Specific properties of probiotic strains: relevance and benefits for the host.
Bubnov RV; Babenko LP; Lazarenko LM; Mokrozub VV; Spivak MY
EPMA J; 2018 Jun; 9(2):205-223. PubMed ID: 29896319
[TBL] [Abstract][Full Text] [Related]
20. Probiotics and nutraceuticals as a new frontier in obesity prevention and management.
Kobyliak N; Falalyeyeva T; Boyko N; Tsyryuk O; Beregova T; Ostapchenko L
Diabetes Res Clin Pract; 2018 Jul; 141():190-199. PubMed ID: 29772287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
